Stock Events

InVivo Therapeutics 

$0.28
0
+$0+0% Today

Statistics

Day High
0.29
Day Low
0.25
52W High
2.16
52W Low
0.2
Volume
4,021
Avg. Volume
3,889,418
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVIVQ. It's not an investment recommendation.

About

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Dr. Richard M. Toselli
Employees
6
Country
DE
ISIN
US46186M6057
WKN
000A3DHEU

Listings